Profiling Parkinson’s disease
A cohort of unselected PD patients who are characterized longitudinally and comprehensively on clinical, medication use, biospecimen (i.e., genetics, blood biomarker, skin biomarker, stool microbiome, cerebral fluid and MRI) and wearable-sensor-derived free-living kinematic data.
Visit ProPark
Members
Investigators | Contacts |
---|---|
|
|
Summary Statistics
No graphics available
Individual Studies
Acronym | Name | Study design | Participants | Countries |
---|---|---|---|---|
ProPark | Profiling Parkinson's disease | Cohort | 1,250 | Netherlands |